Dali Pharmaceuticalco.,Ltd (603963.SS)

CNY 2.96

(-3.27%)

Total Liabilities Summary of Dali Pharmaceuticalco.,Ltd

  • Dali Pharmaceuticalco.,Ltd's latest annual total liabilities in 2023 was 92.7 Million CNY , down -9.4% from previous year.
  • Dali Pharmaceuticalco.,Ltd's latest quarterly total liabilities in 2024 Q1 was 85.58 Million CNY , down -7.68% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported annual total liabilities of 102.33 Million CNY in 2022, down -21.22% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported annual total liabilities of 129.88 Million CNY in 2021, up 20.43% from previous year.
  • Dali Pharmaceuticalco.,Ltd reported quarterly total liabilities of 92.67 Million CNY for 2024 Q2, up 8.28% from previous quarter.
  • Dali Pharmaceuticalco.,Ltd reported quarterly total liabilities of 88.81 Million CNY for 2024 Q3, down -4.16% from previous quarter.

Annual Total Liabilities Chart of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Historical Annual Total Liabilities of Dali Pharmaceuticalco.,Ltd (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 92.7 Million CNY -9.4%
2022 102.33 Million CNY -21.22%
2021 129.88 Million CNY 20.43%
2020 107.85 Million CNY 15.1%
2019 93.7 Million CNY -28.13%
2018 130.38 Million CNY -12.69%
2017 149.33 Million CNY 87.9%
2016 79.47 Million CNY -27.92%
2015 110.25 Million CNY 25.07%
2014 88.15 Million CNY -6.35%
2013 94.13 Million CNY -29.29%
2012 133.12 Million CNY 0.0%

Peer Total Liabilities Comparison of Dali Pharmaceuticalco.,Ltd

Name Total Liabilities Total Liabilities Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 98.029%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY 89.224%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 99.773%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 98.892%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 97.601%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 96.681%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 97.345%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY 86.632%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 99.398%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY 80.28%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 99.305%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY 78.974%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 96.11%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY 69.02%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 99.104%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 94.22%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 95.857%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 95.805%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 99.119%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 97.964%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY 86.49%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 95.869%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 95.302%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 93.98%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 93.705%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 94.237%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY 78.049%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 99.042%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 97.626%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY 82.032%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 99.369%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 97.371%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY 78.763%
China National Medicines Corporation Ltd. 14.87 Billion CNY 99.377%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 98.999%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 97.905%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY 78.493%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY 90.875%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY 79.361%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY 80.52%
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 94.222%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY 90.339%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 94.1%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY 74.159%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 99.837%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 95.102%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 93.787%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 97.265%
Guobang Pharma Ltd. 2.92 Billion CNY 96.83%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY 91.015%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 98.712%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 98.993%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 97.473%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 95.246%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 94.382%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 97.459%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY 88.494%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 98.105%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY 13.399%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY 92.195%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY 89.547%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY 86.683%
CanSino Biologics Inc. 3.86 Billion CNY 97.602%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 93.073%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 98.127%